These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2016850)

  • 1. Mesangial cell turnover: effect of heparin and peptide growth factors.
    Striker LJ; Peten EP; Elliot SJ; Doi T; Striker GE
    Lab Invest; 1991 Apr; 64(4):446-56. PubMed ID: 2016850
    [No Abstract]   [Full Text] [Related]  

  • 2. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation?
    Eng E; Floege J; Young BA; Couser WG; Johnson RJ
    Kidney Int Suppl; 1994 Feb; 45():S45-7. PubMed ID: 8158896
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.
    Polihronis M; Murphy BF; Pearse MJ; Power DA
    Exp Nephrol; 1996; 4(5):271-8. PubMed ID: 8931982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.
    Chadban SJ; Tesch GH; Foti R; Atkins RC; Nikolic-Paterson DJ
    Lab Invest; 1997 May; 76(5):619-27. PubMed ID: 9166281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of heparin on glomerular mesangial cell].
    Zhang M; Guo M; Jin H
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):273-5, 319. PubMed ID: 7656159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glomerulonephritis and cell growth factors].
    Okuda S
    Fukuoka Igaku Zasshi; 1995 Mar; 86(3):75-8. PubMed ID: 7750892
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.
    Jacot TA; Striker GE; Stetler-Stevenson M; Striker LJ
    Lab Invest; 1996 Dec; 75(6):791-9. PubMed ID: 8973474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding EGF-like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis.
    Takemura T; Murata Y; Hino S; Okada M; Yanagida H; Ikeda M; Yoshioka K
    J Pathol; 1999 Nov; 189(3):431-8. PubMed ID: 10547607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of glomerular mesangial cells to progressive glomerulosclerosis.
    Striker LJ; Doi T; Elliot S; Striker GE
    Semin Nephrol; 1989 Dec; 9(4):318-28. PubMed ID: 2688008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth modulation and proteoglycan turnover in cultured mesangial cells.
    Wang A; Fan MY; Templeton DM
    J Cell Physiol; 1994 May; 159(2):295-310. PubMed ID: 8163569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of mesangial cell biology.
    Veis JH
    Contrib Nephrol; 1993; 104():115-26. PubMed ID: 8325023
    [No Abstract]   [Full Text] [Related]  

  • 13. Responses of mesangial cells of autoimmune mice to cytokines.
    Liu YJ; Ooi BS
    J Immunol; 1993 Aug; 151(4):2247-51. PubMed ID: 8345207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory mechanism in glomerular mesangial cell proliferation.
    Haas CS; Schöcklmann HO; Lang S; Kralewski M; Sterzel RB
    J Nephrol; 1999; 12(6):405-15. PubMed ID: 10626832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
    Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
    Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of platelet-derived growth factor in progression of nephropathy].
    Spustová V; Oksa A; Dzúrik R
    Vnitr Lek; 1996 Dec; 42(12):842-8. PubMed ID: 9072884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury.
    Coffey AK; Karnovsky MJ
    Am J Pathol; 1985 Aug; 120(2):248-55. PubMed ID: 3875292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation.
    Kamanna VS; Pai R; Roh DD; Kirschenbaum MA
    Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mRNA's of cytokines and growth factors in experimental glomerulonephritis.
    Onbe T; Kashihara N; Yamasaki Y; Makino H; Ota Z
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):131-8. PubMed ID: 7881864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.